Although not associated with significant differences in maternal and neonatal outcomes, a poor metabolic profile demonstrated by fasting hyperglycemia at OGTT predicted a greater need of insulin therapy and a higher risk of impaired glucose tolerance persistence after childbirth (18). The gene discussed is INS; the disease is Impaired glucose tolerance.